IBM Security Access Manager Container up to 10.0.6.1 Security Configuration privileges management
| CVSS Meta Temp Score | Current Exploit Price (≈) | CTI Interest Score |
|---|---|---|
| 5.7 | $0-$5k | 0.00 |
Summary
A vulnerability labeled as critical has been found in IBM Security Access Manager Container, Security Verify Access Appliance and Security Verify Access Docker up to 10.0.6.1. This vulnerability affects unknown code of the component Security Configuration. Such manipulation leads to privileges management. This vulnerability is traded as CVE-2023-31005. An attack has to be approached locally. Furthermore, there is an exploit available. The affected component should be upgraded.
Details
A vulnerability, which was classified as problematic, has been found in IBM Security Access Manager Container, Security Verify Access Appliance and Security Verify Access Docker up to 10.0.6.1 (Network Authentication Software). Affected by this issue is an unknown part of the component Security Configuration. The manipulation with an unknown input leads to a privileges management vulnerability. Using CWE to declare the problem leads to CWE-269. The product does not properly assign, modify, track, or check privileges for an actor, creating an unintended sphere of control for that actor. Impacted is confidentiality. CVE summarizes:
IBM Security Access Manager Container (IBM Security Verify Access Appliance 10.0.0.0 through 10.0.6.1 and IBM Security Verify Access Docker 10.0.0.0 through 10.0.6.1) could allow a local user to escalate their privileges due to an improper security configuration. IBM X-Force ID: 254767.
The weakness was shared 02/03/2024. The advisory is available at ibm.com. This vulnerability is handled as CVE-2023-31005 since 04/21/2023. Technical details are unknown but a public exploit is available. This vulnerability is assigned to T1068 by the MITRE ATT&CK project.
The exploit is available at packetstormsecurity.com. It is declared as proof-of-concept.
Upgrading eliminates this vulnerability.
The vulnerability is also documented in the vulnerability database at X-Force (254767). If you want to get best quality of vulnerability data, you may have to visit VulDB.
Product
Type
Vendor
Name
Version
License
Website
- Vendor: https://www.ibm.com/
CPE 2.3
CPE 2.2
CVSSv4
VulDB Vector: 🔍VulDB Reliability: 🔍
CVSSv3
VulDB Meta Base Score: 5.8VulDB Meta Temp Score: 5.7
VulDB Base Score: 3.3
VulDB Temp Score: 3.0
VulDB Vector: 🔍
VulDB Reliability: 🔍
NVD Base Score: 7.8
NVD Vector: 🔍
CNA Base Score: 6.2
CNA Vector (IBM Corporation): 🔍
CVSSv2
| AV | AC | Au | C | I | A |
|---|---|---|---|---|---|
| 💳 | 💳 | 💳 | 💳 | 💳 | 💳 |
| 💳 | 💳 | 💳 | 💳 | 💳 | 💳 |
| 💳 | 💳 | 💳 | 💳 | 💳 | 💳 |
| Vector | Complexity | Authentication | Confidentiality | Integrity | Availability |
|---|---|---|---|---|---|
| Unlock | Unlock | Unlock | Unlock | Unlock | Unlock |
| Unlock | Unlock | Unlock | Unlock | Unlock | Unlock |
| Unlock | Unlock | Unlock | Unlock | Unlock | Unlock |
VulDB Base Score: 🔍
VulDB Temp Score: 🔍
VulDB Reliability: 🔍
Exploiting
Class: Privileges managementCWE: CWE-269 / CWE-266
CAPEC: 🔍
ATT&CK: 🔍
Physical: Partially
Local: Yes
Remote: No
Availability: 🔍
Access: Public
Status: Proof-of-Concept
Download: 🔍
EPSS Score: 🔍
EPSS Percentile: 🔍
Price Prediction: 🔍
Current Price Estimation: 🔍
| 0-Day | Unlock | Unlock | Unlock | Unlock |
|---|---|---|---|---|
| Today | Unlock | Unlock | Unlock | Unlock |
Threat Intelligence
Interest: 🔍Active Actors: 🔍
Active APT Groups: 🔍
Countermeasures
Recommended: UpgradeStatus: 🔍
0-Day Time: 🔍
Timeline
04/21/2023 🔍02/03/2024 🔍
02/03/2024 🔍
11/04/2024 🔍
Sources
Vendor: ibm.comAdvisory: ibm.com
Status: Confirmed
CVE: CVE-2023-31005 (🔍)
GCVE (CVE): GCVE-0-2023-31005
GCVE (VulDB): GCVE-100-252794
X-Force: 254767
scip Labs: https://www.scip.ch/en/?labs.20171019
Entry
Created: 02/03/2024 08:55Updated: 11/04/2024 18:14
Changes: 02/03/2024 08:55 (52), 02/25/2024 15:35 (11), 11/04/2024 18:14 (22)
Complete: 🔍
Cache ID: 216::103
If you want to get best quality of vulnerability data, you may have to visit VulDB.
No comments yet. Languages: en.
Please log in to comment.